VectivBio Holding AG (VECT) Forecast, Price Target & Analyst Ratings

Q: What do analysts expect the price target to be for VectivBio Holding AG (VECT)?

8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.

NASDAQ:VECT • CH1109007893

16.85 USD

0 (0%)

Last: Jul 7, 2023, 08:07 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VectivBio Holding AG (VECT).

Consensus Price Target

Price Target

$18.36

+ 8.96% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: N/A
Period: Q1 / 2023
EPS Estimate: -$0.44
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

47.50%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$18.36

Upside

+ 8.96%

From current price of $16.85 to mean target of $18.36, Based on 8 analyst forecasts

Low

$17.17

Median

$17.34

High

$22.05

Price Target Revisions

1 Month

0.93%

3 Months

-20.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for VECT. The average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.

The average price target has been revised downward by 20% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

47.50%

VECT was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about VECT.

In the last month the buy percentage fell by 28 points. So the trust of analysts is decreasing.

VECT was analyzed by 8 analysts. More opinions would make the average more meaningful.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2023-05-23	SVB Leerink	Downgrade	Outperform -> Market Perform
2023-05-23	Credit Suisse	Downgrade	Outperform -> Neutral
2023-05-23	Piper Sandler	Downgrade	Overweight -> Neutral
2023-04-20	Piper Sandler	Maintains	Overweight
2022-12-13	Jefferies	Initiate	Buy
2022-10-13	SVB Leerink	Maintains	Outperform
2022-07-01	Piper Sandler	Initiate	Overweight
2021-05-04	SVB Leerink	Initiate	Outperform
2021-05-04	Credit Suisse	Initiate	Outperform
2021-05-04	B of A Securities	Initiate	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: N/A
Period: Q1 / 2023
EPS Estimate: -$0.44
Revenue Estimate
Revenue Q2Q: -100.00%
EPS Q2Q: 22.75%
Number of Analysts: 3

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

0.00%

EPS (3 Months)

4.44%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth					N/A	N/A 1,226.27%	N/A 660.11%	N/A 249.26%	N/A 84.49%	N/A 45.36%	N/A 28.16%	N/A 16.64%
EBITDA YoY % growth	-24.17M	-56.99M -135.79%	-86.413M -51.63%	-80.285M 7.09%	N/A -70.15%	N/A -8.60%	N/A	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	-24.32M	-57.26M -135.44%	-86.716M -51.44%	-80.524M 7.14%	N/A -57.74%	N/A -12.51%	N/A 5.87%	N/A 61.79%	N/A 239.63%	N/A 160.07%	N/A 51.49%	N/A 20.23%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS YoY % growth	N/A	N/A	N/A	N/A 42.81%	N/A 8.67%	N/A -5.37%	N/A 1.78%	N/A 47.78%	N/A 195.83%	N/A 62.50%	N/A 60.87%	N/A 30.98%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 23	Q2 / 23	Q3 / 23	Q4 / 23	Q1 / 24	Q2 / 24	Q3 / 24	Q4 / 24
EPS Q2Q % growth	-0.44 22.75%	-0.45 -104.65%	-0.47 34.57%	-0.45 14.84%	-0.44	-0.47 -4.55%	-0.36 23.91%	-0.56 -25.00%
Revenue Q2Q % growth	-100.00%		-100.00%				10.2M
EBITDA Q2Q % growth	-27.724M -2.56%	-28.223M 8.37%	-30.569M -9.77%	-49.266M 0.20%	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-27.336M -16.80%	-28.152M 8.96%	-29.07M -7.12%	-30.6M 38.31%	-30.6M -11.94%	-32.64M -15.94%	-24.48M 15.79%	-42.468M -38.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

1.79%

EPS Next 5 Year

19.85%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

44.85%

Revenue Next 5 Year

81.29%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VectivBio Holding AG / VECT Forecast FAQ

What do analysts expect the price target to be for VectivBio Holding AG (VECT)?

8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.

What are the consensus estimates for VECT stock next earnings?

The consensus EPS estimate for the next earnings of VectivBio Holding AG (VECT) is -0.44 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for VECT stock?

The number of analysts covering VectivBio Holding AG (VECT) is 8.

Analyst forecast overview

Forecast Snapshot